Augustine Lawlor
Affiliations
- Chief Operating Officer at Leap Therapeutics Inc. (LPTX), 2025-04-02
- at Catalyst Biosciences Inc. (CBIO), 2023-09-01
- Director at Cardiovascular Systems Inc (CSII), 2023-04-27
- Director at Globeimmune Inc (GBIM), 2016-03-18
- Large Shareholder at Proteostasis Therapeutics Inc. (PTI), 2016-02-17
- Large Shareholder at Trevena Inc (TRVN), 2014-02-07
- Large Shareholder at Tetralogic Pharmaceuticals Corp (TLOG), 2013-12-17
- Director at Human Genome Sciences Inc (HGSI), 2012-08-01
- Large Shareholder at Radius Health Inc. (NONE), 2011-12-23
- Large Shareholder at Pharmathene Inc (PIP), 2010-11-05
Insider Trading: Purchases See All
| Symbol | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| LPTX | $1.75 | 571,428 | $999,999.00 | 4,114,804 | 2019-02-05 | Filing |
| LPTX | $6.09 | 1,057,769 | $6,436,524.37 | 3,573,376 | 2017-11-14 | Filing |
Insider Trading: Sales See All
| Symbol | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| CBIO | $6.10 | 69,401 | $423,505.72 | 0 | 2020-02-25 | Filing |
| GBIM | $1.55 | 11,000 | $17,050.00 | 463,267 | 2016-03-18 | Filing |
| GBIM | $2.05 | 2,500 | $5,125.00 | 474,267 | 2016-03-15 | Filing |
| GBIM | $1.60 | 16,300 | $26,080.00 | 476,767 | 2016-03-11 | Filing |
| GBIM | $1.35 | 200 | $270.00 | 493,067 | 2016-03-10 | Filing |